URL copied
Cipla launches ViraGen RT-PCR test.
Cipla Limited on Thursday announced the commercialisation of a polymerase chain reaction (RT-PCR) test kit âViraGen for COVID-19 in India, in partnership with Ubio Biotechnology Systems Pvt. Ltd.
ViraGen is Cipla s third offering in the Covid-19 testing segment. Cipla already has partnerships for antibody detection kit and antigen test kits.
ViraGen is a real-time detection kit approved by the ICMR (Indian Council of Medical Research) and is based on multiplex PCR technology. It helps to identify and detect SARS CoV-2 N Gene and ORF Lab Gene with the sensitivity of 98.6% and the specificity of 98.8% as compared to a standard ICMR test.
Cipla Limited on Thursday announced the commercialisation of a polymerase chain reaction (RT-PCR) test kit ViraGen for COVID-19 in India, in partnership with Ubio Biotechnology Systems Pvt. Ltd.ViraGen is Cipla s third offering in the Covid-19 .
Cipla launches rapid antigen test kits for detecting Covid-19 hindustantimes.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from hindustantimes.com Daily Mail and Mail on Sunday newspapers.
Cipla settles its litigation with Celgene Corporation daijiworld.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from daijiworld.com Daily Mail and Mail on Sunday newspapers.